Emerging Diseases News

Researchers developed a low-cost rapid test to detect an invasive species of mosquito that has adapted to live near humans in urban environments, which they hope can be used in areas far from medical labs.

The risk for developing long COVID declined over the course of the pandemic but has remained significant, researchers reported.

Ivory Coast administered the first doses of the world’s second malaria vaccine this week, according to the vaccine’s manufacturers, marking the latest development in a decades-long effort to control the deadly mosquito-borne disease.

Doxycycline was safe and may be effective as adjunctive therapy to antiseizure medication in young people with nodding syndrome, according to research from Lancet Global Health.

Children hospitalized with SARS-CoV-2 or an inflammatory syndrome associated with SARS-CoV-2 infection who experience severe neurological manifestations may be at a higher risk for long-term impairment, a study found.

Together, a group of viruses nicknamed “FLiRT” have emerged to become the most common SARS-CoV-2 variants in the country.

The following case, provided by Michael Cater, MD, a pediatrician at Children’s Hospital of Orange County, California, is the first of a two-part series.

We checked in with CDC Director Mandy K. Cohen, MD, MPH, for an update on the agency’s efforts to modernize the nation’s disease surveillance and data systems and improve how the CDC communicates with the public and physicians.

The geographic range of ticks in the United States is expanding, which may place more people than ever at risk for tick-borne diseases. We asked Richard S. Ostfeld, PhD, for an explanation.

Lyme disease is the most common vector-borne disease in the United States, and although cases have steadily increased — and are estimated to be significantly undercounted — there is no vaccine to prevent it.